Hoechst/Andrx Cardizem CD Settlement is Pro-Competitive - Andrx

The September 1997 generic Cardizem CD agreement between Andrx and Hoechst Marion Roussel is pro-competitive because it allows for the launch of a generic once-daily diltiazem regardless of the outcome of the patent suit between the two firms, Andrx maintained in response to class action suits.